Generics - Antibiotics and Infectious diseases

Filter

Popular Filters

26 to 33 of 33 results

ViroPharma stock plunges on bad news for Vancocin; Sanofi patents invalidated

11-04-2012

ViroPharma I (Nasdaq: VPHM) saw its shares plunge 19% to $23.25 yesterday after it announced that the…

Antibiotics and Infectious diseasesApotexGenericsHospiraLegalNorth AmericaOncologyPatentsPharmaceuticalRegulationSanofiTaxotereVancocinViroPharmaWatson Pharmaceuticals

Hospira challenges Cubist patents on Cubicin

10-02-2012

US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) says that it has received a Paragraph IV Notice Letter…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsGenericsHospiraNorth AmericaPatentsPharmaceuticalResearch

Generic launches of irinotecan, Primaxin and Merrem

08-02-2012

Japan’s ASKA Pharmaceuticals has announced the launch of irinotecan, the active ingredient of Campto…

ActavisAntibiotics and Infectious diseasesAPP PharmaceuticalsASKA PharmaceuticalsFresenius KabiGenericsirinotecanMarkets & MarketingMerrem I.V.Oncology

Zydus Cadila acquires Mumbai-based Biochem

21-12-2011

Indian drug firm Zydus Cadila says it has acquired a 100% stake in Biochem, described as one of the top…

Antibiotics and Infectious diseasesAsia-PacificBiochemGenericsMergers & AcquisitionsZydus Cadila

US hospital pharmacy and therapeutics committees decision-making process for antibiotics and antifungal therapies

15-11-2011

In addition to managing the hospital’s anti-infective formulary, hospital pharmacy and therapeutics…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingNorth AmericaPharmaceutical

Akorn in up to $58 million deal to acquire certain assets of India’s Kilitch Drugs and NBZ Pharma

06-10-2011

US niche generics maker Akorn (Nasdaq: AKRX) has entered into an agreement to acquire certain assets…

AkornAntibiotics and Infectious diseasesAsia-PacificGenericsKilitch DrugsMergers & AcquisitionsOncologyOphthalmics

26 to 33 of 33 results

Back to top